Advancing Generic Drug Development: Translating Science to Approval – Day 2 – Session 6 Published 2022-10-04 Download video MP4 360p Download video MP4 720p Recommendations 1:50:00 Advancing Generic Drug Development: Translating Science to Approval – Day 2 – Session 7 02:21 What does the FDA do after drugs are approved? 02:55 FDA Patient Listening Sessions: Community Perspectives 28:51 Overview of Warning Letters for Online Retailers 03:17 How does the FDA approve new drugs? 02:28 What is FDA’s role in regulating drugs? 53:25 OTC Monograph Reform: OMOR Format and Content & Electronic Submissions 3:27:43 September 11-12, 2023 Meeting of the Nonprescription Drugs Advisory Committee (NDAC) - Day 2 1:48:54 2022 FDA Virtual Digital Transformation Symposium – Day 2 Afternoon Session 8:05:24 Advancing Generic Drugs Development: Translating Science to Approval 2023 - Day 1 00:53 Science is our Business! 4:23:03 Listening Session: Developing FDA’s Center for Tobacco Products’ Strategic Plan (Aug. 22, 2023) 7:58:37 Advancing Generic Drugs Development: Translating Science to Approval 2023 - Day 2 7:49:25 September 13, 2023 Meeting of the Cardiovascular and Renal Drugs Advisory Committee (CRDAC) 01:14 At-Home COVID-19 Test Resources 01:01 From Mammograms to Microwaves | Researching FDA 8:22:00 September 11-12, 2023 Meeting of the Nonprescription Drugs Advisory Committee (NDAC) - Day 1 Similar videos 2:28:46 Advancing Generic Drug Development: Translating Science to Approval – Day 1 – Session 2 1:47:48 Advancing Generic Drug Development: Translating Science to Approval – Day 2 – Session 5 1:43:45 Advancing Generic Drug Development: Translating Science to Approval – Day 1 – Session 3 06:07 Advancing Generic Drug Development: Translating Science to Approval, Day One Closing Remarks 1:44:40 Advancing Generic Drug Development: Translating Science to Approval - Day 1 – Keynote and Session 1 50:27 Model-Integrated Evidence for Generic Drug Development – Session 1B 1:31:52 Complex Generics: Topical Products, Part 2 50:54 Model-Integrated Evidence for Generic Drug Development – Session 1A 1:27:05 Generic Drugs Forum 2022 – Day 2, Session 4 29:55 Using MIDD and Model Integrated Evidence to Support Generic Drug Development and Assessment 1:25:59 Complex Generics: Complex Injectables, Ophthalmic, and Otic Products, Part 1 1:47:25 Considerations in Assessing Generic Drug Products of Oral Dosage Forms 1:56:38 FDA NanoDay 2022 Session 3 6:10:51 Advancing the Development and Implementation of Analysis Data Standards 1:18:43 PACCARB 6th Public Meeting Day 2: PACCARB WGs– Animal, Council Q&A, Public Comments and Adjourn 08:04 Christina Hoff Sommers on How The Illiberal Left Changed Feminism | The Megyn Kelly Show 20:26 Repurposing Drugs in the age of COVID-19 by JOHN J SEMAN CEO of Revitale Pharmaceuticals 7:42:52 Participant Engagement and Health Equity Workshop - July 1-2, 2015 - Day 1 More results